This document summarizes key concepts related to diffusion, dissolution, and pharmacokinetic parameters. It defines diffusion as the spontaneous migration of molecules from high to low concentration regions driven by Brownian motion. Fick's laws describe the rate of diffusion being proportional to the concentration gradient. Dissolution is defined as a solid solute dissolving in a solvent to form a solution. Several parameters influence dissolution rate including surface area, diffusion coefficient, and concentration gradient. Pharmacokinetics describes the absorption, distribution, metabolism, and excretion of drugs and key parameters include Cmax, Tmax, and AUC which describe the concentration of drugs in plasma over time.
This document discusses modern pharmaceutics and preformulation concepts. It begins with an introduction to preformulation, which involves investigating a drug's physical and chemical properties alone and with excipients. This information guides dosage form development. The document then discusses drug-excipient interactions and compatibility testing methods. It also covers topics like solid dispersions, emulsions, suspensions, and parenteral product formulation and testing requirements.
This document provides an overview of preformulation studies for drug development. It discusses the importance of characterizing key physicochemical properties of drug substances such as solubility, ionization constants, melting point, and polymorphism. It also covers the role of excipients and how drug-excipient interactions can impact stability. The document concludes with sections on stability studies, factors that influence stability, and guidelines for stability testing procedures and frequencies.
DIffusion, Dissolution and Pharmacokinetic Parameters.pptxKailas Mali
This document discusses various parameters used to study drug release and dissolution from pharmaceutical dosage forms, including diffusion parameters, dissolution parameters, pharmacokinetic parameters, and models like Higuchi and Peppas plots. It defines key terms like diffusion, flux, Fick's first law, and discusses how factors like agitation, pH, surfactants, viscosity, and temperature can influence dissolution. Key drug release mechanisms and models are also summarized.
This presentation includes the detail information about the physics of tablet compression and compaction, Compression, Effect of friction, distribution of forces, compaction profiles,solubility.
This document discusses single shot vaccines that can provide protection against multiple diseases with only one injection. It describes how single shot vaccines work by combining an antigen, adjuvant, and microsphere component that encapsulates and slowly releases the antigen. Key factors in developing these vaccines include controlling particle size, optimizing encapsulation efficiency, and regulating antigen release from the biodegradable microspheres. Single shot vaccines offer advantages like improved patient compliance and lower costs compared to traditional multi-dose vaccines.
This document discusses different types of rate controlled drug delivery systems. It begins by introducing controlled release drug delivery and distinguishing it from sustained release. It then classifies controlled release systems into three main categories: rate programmed, activation modulated, and feedback regulated systems. Within each category it describes several examples of systems, identifying how drug release is controlled in each case. Key factors that can affect controlled release are also listed. The document aims to provide an overview of controlled drug delivery technologies with classifications and examples.
This document discusses excipients and their role in drug formulations. It notes that excipients are ingredients other than the active pharmaceutical ingredient that are used to formulate dosage forms. Excipients can act as protective agents, bulking agents, and can improve drug bioavailability. The document then lists common types of excipients and potential interactions between drugs and excipients, such as physical, chemical, biopharmaceutical, and excipient-excipient interactions. It describes several analytical techniques used to detect drug-excipient interactions, including DSC, accelerated stability studies, FT-IR, DRS, chromatography methods, and others.
The document discusses the effect of various parameters on drug dissolution. It describes how agitation, pH, viscosity, temperature and other properties of the dissolution medium influence the dissolution rate. The amount of dissolution medium and maintenance of sink conditions are also important. Various dissolution models like Hixson-Crowell are presented.
This document discusses modern pharmaceutics and preformulation concepts. It begins with an introduction to preformulation, which involves investigating a drug's physical and chemical properties alone and with excipients. This information guides dosage form development. The document then discusses drug-excipient interactions and compatibility testing methods. It also covers topics like solid dispersions, emulsions, suspensions, and parenteral product formulation and testing requirements.
This document provides an overview of preformulation studies for drug development. It discusses the importance of characterizing key physicochemical properties of drug substances such as solubility, ionization constants, melting point, and polymorphism. It also covers the role of excipients and how drug-excipient interactions can impact stability. The document concludes with sections on stability studies, factors that influence stability, and guidelines for stability testing procedures and frequencies.
DIffusion, Dissolution and Pharmacokinetic Parameters.pptxKailas Mali
This document discusses various parameters used to study drug release and dissolution from pharmaceutical dosage forms, including diffusion parameters, dissolution parameters, pharmacokinetic parameters, and models like Higuchi and Peppas plots. It defines key terms like diffusion, flux, Fick's first law, and discusses how factors like agitation, pH, surfactants, viscosity, and temperature can influence dissolution. Key drug release mechanisms and models are also summarized.
This presentation includes the detail information about the physics of tablet compression and compaction, Compression, Effect of friction, distribution of forces, compaction profiles,solubility.
This document discusses single shot vaccines that can provide protection against multiple diseases with only one injection. It describes how single shot vaccines work by combining an antigen, adjuvant, and microsphere component that encapsulates and slowly releases the antigen. Key factors in developing these vaccines include controlling particle size, optimizing encapsulation efficiency, and regulating antigen release from the biodegradable microspheres. Single shot vaccines offer advantages like improved patient compliance and lower costs compared to traditional multi-dose vaccines.
This document discusses different types of rate controlled drug delivery systems. It begins by introducing controlled release drug delivery and distinguishing it from sustained release. It then classifies controlled release systems into three main categories: rate programmed, activation modulated, and feedback regulated systems. Within each category it describes several examples of systems, identifying how drug release is controlled in each case. Key factors that can affect controlled release are also listed. The document aims to provide an overview of controlled drug delivery technologies with classifications and examples.
This document discusses excipients and their role in drug formulations. It notes that excipients are ingredients other than the active pharmaceutical ingredient that are used to formulate dosage forms. Excipients can act as protective agents, bulking agents, and can improve drug bioavailability. The document then lists common types of excipients and potential interactions between drugs and excipients, such as physical, chemical, biopharmaceutical, and excipient-excipient interactions. It describes several analytical techniques used to detect drug-excipient interactions, including DSC, accelerated stability studies, FT-IR, DRS, chromatography methods, and others.
The document discusses the effect of various parameters on drug dissolution. It describes how agitation, pH, viscosity, temperature and other properties of the dissolution medium influence the dissolution rate. The amount of dissolution medium and maintenance of sink conditions are also important. Various dissolution models like Hixson-Crowell are presented.
1) Tablet compression involves the application of force to reduce the volume of powder materials through three main processes: compression, compaction, and consolidation. Compression removes air, compaction rearranges particles, and consolidation increases strength through bonding.
2) Key forces involved in compression include inter-particulate and die wall friction, which can be reduced by adding glidants and lubricants, respectively. Distribution forces transmit pressure from the punches to the powder bed and die wall.
3) Compaction profiles examine the relationship between axial and radial pressure. They provide information on elastic versus plastic deformation and ejection forces.
Physics of Tablet compression is very useful during study of the tablet. It contains the mechanism of tablet compression. It also contains the process of tablet compression.
1. Dissolution is the process by which a solid substance dissolves in a solvent to form a solution. The rate of dissolution depends on factors like temperature, solvent composition, and the liquid/solid interface area.
2. There are several theories that describe the drug dissolution process, including the diffusion layer model, penetration or surface renewal theory, and interfacial barrier model. The most common model is the diffusion layer model, which involves the formation of a saturated film at the solid/liquid interface and diffusion of the drug through this layer.
3. Key factors that affect drug dissolution include the solubility and permeability of the drug substance, the pH and volume of the dissolution medium, and the design of
Self micro-emulsifying drug delivery system (SMEDDS)Himal Barakoti
This document discusses self-microemulsifying drug delivery systems (SMEDDS), including their background, mechanism of action, formulations, stability testing, advantages, and applications. SMEDDS are isotropic mixtures of oils, surfactants, and co-surfactants that form fine oil-in-water emulsions upon mild agitation followed by dilution in gastrointestinal fluids. They can improve the oral absorption of poorly water-soluble drugs and enhance their bioavailability. SMEDDS formulations typically contain an oil, surfactant, co-surfactant, and drug. Their small particle size allows efficient drug release in the GI tract. Stability testing evaluates factors like temperature effects and in vitro drug release. SMEDDS
This document discusses different types of controlled drug delivery systems. It classifies systems as rate preprogrammed, activation modulated, or feedback regulated. Rate preprogrammed systems are further broken down into polymer membrane permeation controlled systems, polymer matrix diffusion controlled systems, and microreservoir partition controlled systems. The key aspects and release kinetics of each system type are described through examples. Factors that influence drug release rates from these systems include membrane thickness, drug solubility, diffusivity, and partitioning coefficients.
This presentation includes introduction of validation, types of validation,process validation of dosage forms[ solids(tablets),liquids(emulsions and suspensions),semisolids.
This document discusses compaction profiles, which establish the relationship between axial and radial force during tablet punching. It describes three types of compaction profiles: force time profiles, force displacement profiles, and die wall profiles. Force time profiles characterize the compression, dwell, and decompression phases. Force displacement profiles assess material deformation behavior. Die wall force profiles provide information on friction between materials and the die wall. Compaction profiles provide information on a material's compaction behavior and properties that can be used to optimize the tableting process.
This document discusses sustained release and controlled release drug formulations. It begins with an introduction and overview of basic concepts. It then discusses the advantages and disadvantages of sustained release formulations. Several key factors that influence sustained release drug formulations are described, including drug properties, route of administration, target sites, and whether the therapy is for acute or chronic conditions. Different physical approaches related to drug solubility, partitioning, and stability are covered.
Consolidation, effect of friction, distribution of forces, compaction profileZahid1392
This document defines key terms related to powder compaction such as compression, consolidation, and compaction. It describes consolidation as an increase in mechanical strength from particle interactions. The consolidation process involves cold welding and fusion bonding. Factors that affect consolidation include material properties, surface area, contaminants, and inter-surface distances. It also discusses forces involved in compaction such as frictional, distributional, radial, and ejectional forces. Frictional forces arise from particle-particle and die wall contacts. Distributional forces balance axial forces applied to the powder mass. Compaction profiles result from measuring radial pressure against axial pressure.
it provide a brief note on the drug excipient interaction and various technique to find it which is a part of preformulation studies. it gives help to mpharm(pharmaceutics) students. i.
Kinetics of Stability & Stability Testing Sidharth Mehta
This document discusses kinetics of stability and stability testing. It defines drug kinetics as how a drug changes over time and explains zero and first order reaction kinetics. Factors affecting reaction rate and types of drug degradation are covered. Stability testing is defined and its importance, types, methods, guidelines and climatic zones are summarized. Methods for estimating shelf life and determining expiration dates are also presented.
The document discusses drug product performance evaluation through in vitro dissolution testing. It provides details on factors that influence drug dissolution like drug substance properties, formulation composition, manufacturing process, and dissolution test conditions. The key goals of in vitro drug product testing are to characterize drug potency and release rate from oral dosage forms, provide information for formulation development, and ensure quality, comparability and stability over time. Common tests include disintegration testing and dissolution testing using apparatus specified in pharmacopeias to simulate gastrointestinal conditions. The results of in vitro testing aid product development and assessment of shelf-life and quality.
Description about a type of activation modulated drug delivery system, which a type of control drug delivery system.
Also, give a detailed description about each subclassification.
CrDDS is one which delivers the drug at a predetermined rate, for locally or systematically, for a prolong period of time.
CMC, post approval regulatory affairs, etcJayeshRajput7
this document covers points such as CMC, post approval regulatory affairs, regulation for combination products, and medical devices, common technical document (CTD) and electronic common technical document (eCTD) format, industry and FDA liasion, ICH guidelines of ICH Q,S,E,M, regulatory requirements of EU, MHRA, TGA and ROW countries.
The document discusses the physics of tablet compression. It describes the processes of compaction, consolidation and compression that tablets undergo in their production. It outlines the main stages of compression including particle rearrangement, deformation, fragmentation and bonding. It also discusses the forces involved and common compaction profiles and equations used to describe the process, including the Heckel and Kawakita equations. The document provides an overview of the key concepts and stages in understanding the physics behind tablet production through compression.
This document summarizes key parameters studied in the consolidation of pharmaceutical formulations, including diffusion parameters described by Higuchi's equation, dissolution parameters like the effects of agitation and pH, and pharmacokinetic parameters like Cmax, Tmax, and AUC. It also discusses the Heckel plot and similarity factors f1 and f2 for comparing drug release profiles.
ICH and WHO Guideline for Validation and Calibration.pptxRAHUL PAL
Validation: Action of proving and documenting that any process, procedure or method actually and consistently leads to the expected results.
Calibration: The set of operations that establish, under specified conditions, the relationship between values indicated by an instrument or system for measuring (for example, weight, temperature and pH), recording, and controlling, or the values represented by a material measure, and the corresponding known values of a reference standard.
Current Goods Manufacturing Practice & Industrial ManagementLukman N Kerur
This document provides an overview of CGMP (Current Good Manufacturing Practice) and industrial management. It discusses key aspects of CGMP such as plant layout, services, equipment, production organization, materials management, handling and transportation, inventory management, production planning and control, sales forecasting, budgeting, quality management, and industrial relationships. The objectives of CGMP are to ensure product quality and consistency in manufacturing. Key elements outlined include facilities and equipment requirements, quality control of materials, production systems, and regulatory compliance.
This document summarizes various consolidation and dissolution parameters relevant to pharmaceutical dosage forms. It discusses diffusion parameters per Higuchi kinetics, dissolution parameters like effect of agitation and pH, pharmacokinetic parameters like Cmax and AUC, and methods to compare dissolution profiles using similarity factors f1 and f2. The Heckel plot is also introduced as a method to study mechanisms of powder consolidation under compression.
This document discusses various parameters studied in the consolidation of pharmaceutical formulations, including diffusion, dissolution, pharmacokinetic parameters, and similarity factors. It provides details on Higuchi's equation for diffusion parameters and the Hixson-Crowell cube root law. For dissolution parameters, the effects of agitation, pH, surface tension, viscosity, additives, medium volume and temperature are examined. Pharmacokinetic parameters like peak plasma concentration, time to peak concentration, and area under the curve are also summarized.
1) Tablet compression involves the application of force to reduce the volume of powder materials through three main processes: compression, compaction, and consolidation. Compression removes air, compaction rearranges particles, and consolidation increases strength through bonding.
2) Key forces involved in compression include inter-particulate and die wall friction, which can be reduced by adding glidants and lubricants, respectively. Distribution forces transmit pressure from the punches to the powder bed and die wall.
3) Compaction profiles examine the relationship between axial and radial pressure. They provide information on elastic versus plastic deformation and ejection forces.
Physics of Tablet compression is very useful during study of the tablet. It contains the mechanism of tablet compression. It also contains the process of tablet compression.
1. Dissolution is the process by which a solid substance dissolves in a solvent to form a solution. The rate of dissolution depends on factors like temperature, solvent composition, and the liquid/solid interface area.
2. There are several theories that describe the drug dissolution process, including the diffusion layer model, penetration or surface renewal theory, and interfacial barrier model. The most common model is the diffusion layer model, which involves the formation of a saturated film at the solid/liquid interface and diffusion of the drug through this layer.
3. Key factors that affect drug dissolution include the solubility and permeability of the drug substance, the pH and volume of the dissolution medium, and the design of
Self micro-emulsifying drug delivery system (SMEDDS)Himal Barakoti
This document discusses self-microemulsifying drug delivery systems (SMEDDS), including their background, mechanism of action, formulations, stability testing, advantages, and applications. SMEDDS are isotropic mixtures of oils, surfactants, and co-surfactants that form fine oil-in-water emulsions upon mild agitation followed by dilution in gastrointestinal fluids. They can improve the oral absorption of poorly water-soluble drugs and enhance their bioavailability. SMEDDS formulations typically contain an oil, surfactant, co-surfactant, and drug. Their small particle size allows efficient drug release in the GI tract. Stability testing evaluates factors like temperature effects and in vitro drug release. SMEDDS
This document discusses different types of controlled drug delivery systems. It classifies systems as rate preprogrammed, activation modulated, or feedback regulated. Rate preprogrammed systems are further broken down into polymer membrane permeation controlled systems, polymer matrix diffusion controlled systems, and microreservoir partition controlled systems. The key aspects and release kinetics of each system type are described through examples. Factors that influence drug release rates from these systems include membrane thickness, drug solubility, diffusivity, and partitioning coefficients.
This presentation includes introduction of validation, types of validation,process validation of dosage forms[ solids(tablets),liquids(emulsions and suspensions),semisolids.
This document discusses compaction profiles, which establish the relationship between axial and radial force during tablet punching. It describes three types of compaction profiles: force time profiles, force displacement profiles, and die wall profiles. Force time profiles characterize the compression, dwell, and decompression phases. Force displacement profiles assess material deformation behavior. Die wall force profiles provide information on friction between materials and the die wall. Compaction profiles provide information on a material's compaction behavior and properties that can be used to optimize the tableting process.
This document discusses sustained release and controlled release drug formulations. It begins with an introduction and overview of basic concepts. It then discusses the advantages and disadvantages of sustained release formulations. Several key factors that influence sustained release drug formulations are described, including drug properties, route of administration, target sites, and whether the therapy is for acute or chronic conditions. Different physical approaches related to drug solubility, partitioning, and stability are covered.
Consolidation, effect of friction, distribution of forces, compaction profileZahid1392
This document defines key terms related to powder compaction such as compression, consolidation, and compaction. It describes consolidation as an increase in mechanical strength from particle interactions. The consolidation process involves cold welding and fusion bonding. Factors that affect consolidation include material properties, surface area, contaminants, and inter-surface distances. It also discusses forces involved in compaction such as frictional, distributional, radial, and ejectional forces. Frictional forces arise from particle-particle and die wall contacts. Distributional forces balance axial forces applied to the powder mass. Compaction profiles result from measuring radial pressure against axial pressure.
it provide a brief note on the drug excipient interaction and various technique to find it which is a part of preformulation studies. it gives help to mpharm(pharmaceutics) students. i.
Kinetics of Stability & Stability Testing Sidharth Mehta
This document discusses kinetics of stability and stability testing. It defines drug kinetics as how a drug changes over time and explains zero and first order reaction kinetics. Factors affecting reaction rate and types of drug degradation are covered. Stability testing is defined and its importance, types, methods, guidelines and climatic zones are summarized. Methods for estimating shelf life and determining expiration dates are also presented.
The document discusses drug product performance evaluation through in vitro dissolution testing. It provides details on factors that influence drug dissolution like drug substance properties, formulation composition, manufacturing process, and dissolution test conditions. The key goals of in vitro drug product testing are to characterize drug potency and release rate from oral dosage forms, provide information for formulation development, and ensure quality, comparability and stability over time. Common tests include disintegration testing and dissolution testing using apparatus specified in pharmacopeias to simulate gastrointestinal conditions. The results of in vitro testing aid product development and assessment of shelf-life and quality.
Description about a type of activation modulated drug delivery system, which a type of control drug delivery system.
Also, give a detailed description about each subclassification.
CrDDS is one which delivers the drug at a predetermined rate, for locally or systematically, for a prolong period of time.
CMC, post approval regulatory affairs, etcJayeshRajput7
this document covers points such as CMC, post approval regulatory affairs, regulation for combination products, and medical devices, common technical document (CTD) and electronic common technical document (eCTD) format, industry and FDA liasion, ICH guidelines of ICH Q,S,E,M, regulatory requirements of EU, MHRA, TGA and ROW countries.
The document discusses the physics of tablet compression. It describes the processes of compaction, consolidation and compression that tablets undergo in their production. It outlines the main stages of compression including particle rearrangement, deformation, fragmentation and bonding. It also discusses the forces involved and common compaction profiles and equations used to describe the process, including the Heckel and Kawakita equations. The document provides an overview of the key concepts and stages in understanding the physics behind tablet production through compression.
This document summarizes key parameters studied in the consolidation of pharmaceutical formulations, including diffusion parameters described by Higuchi's equation, dissolution parameters like the effects of agitation and pH, and pharmacokinetic parameters like Cmax, Tmax, and AUC. It also discusses the Heckel plot and similarity factors f1 and f2 for comparing drug release profiles.
ICH and WHO Guideline for Validation and Calibration.pptxRAHUL PAL
Validation: Action of proving and documenting that any process, procedure or method actually and consistently leads to the expected results.
Calibration: The set of operations that establish, under specified conditions, the relationship between values indicated by an instrument or system for measuring (for example, weight, temperature and pH), recording, and controlling, or the values represented by a material measure, and the corresponding known values of a reference standard.
Current Goods Manufacturing Practice & Industrial ManagementLukman N Kerur
This document provides an overview of CGMP (Current Good Manufacturing Practice) and industrial management. It discusses key aspects of CGMP such as plant layout, services, equipment, production organization, materials management, handling and transportation, inventory management, production planning and control, sales forecasting, budgeting, quality management, and industrial relationships. The objectives of CGMP are to ensure product quality and consistency in manufacturing. Key elements outlined include facilities and equipment requirements, quality control of materials, production systems, and regulatory compliance.
This document summarizes various consolidation and dissolution parameters relevant to pharmaceutical dosage forms. It discusses diffusion parameters per Higuchi kinetics, dissolution parameters like effect of agitation and pH, pharmacokinetic parameters like Cmax and AUC, and methods to compare dissolution profiles using similarity factors f1 and f2. The Heckel plot is also introduced as a method to study mechanisms of powder consolidation under compression.
This document discusses various parameters studied in the consolidation of pharmaceutical formulations, including diffusion, dissolution, pharmacokinetic parameters, and similarity factors. It provides details on Higuchi's equation for diffusion parameters and the Hixson-Crowell cube root law. For dissolution parameters, the effects of agitation, pH, surface tension, viscosity, additives, medium volume and temperature are examined. Pharmacokinetic parameters like peak plasma concentration, time to peak concentration, and area under the curve are also summarized.
Group 9 Biopharmaceutical & Pharmacokinetic Considerations.pptxfariahqaiser1
The document discusses considerations for designing controlled release drug delivery systems. It describes four main mechanisms for controlling drug release: dissolution control, diffusion control, osmotic pressure control, and ion exchange control. Factors that influence the design of controlled release systems include biopharmaceutical characteristics of the drug like molecular weight, solubility, partition coefficient, and pKa, as well as pharmacokinetic characteristics. The biopharmaceutical properties that are most important to consider are molecular size, diffusion coefficient, aqueous solubility, partition coefficient, and ionization state of the drug at physiological pH levels. Controlled release systems aim to optimize how the body processes a drug to maximize its effects.
Controlled Release Drug Delivery Systems - Types, Methods and ApplicationsSuraj Choudhary
This document discusses factors affecting the design of controlled release drug delivery systems (CRDDS). It outlines several key considerations for CRDDS design including selection of the drug candidate, medical and biological rationale, and physicochemical properties. It also discusses important physicochemical factors such as solubility, partition coefficient, molecular size and diffusivity, dose size, complexation, ionization constant, drug stability, and protein binding that influence CRDDS design. Finally, it briefly describes dissolution-controlled and diffusion-controlled release approaches for developing CRDDS.
This document discusses various parameters used to characterize drug release from pharmaceutical formulations. It describes diffusion parameters defined by Higuchi's equation and plots. Dissolution parameters like the effects of agitation, pH, temperature, and medium properties are outlined. Pharmacokinetic parameters including Cmax, Tmax, and AUC are defined. The Heckel equation is presented as a method to analyze powder compaction. Similarity factors f1 and f2 are introduced to compare dissolution profiles. The Higuchi and Korsmeyer-Peppas models for drug release are presented.
This document discusses various parameters used to characterize drug release from pharmaceutical formulations, including diffusion parameters described by Higuchi's equation, dissolution parameters like the effects of agitation and pH, and pharmacokinetic parameters like Cmax, Tmax, and AUC. It also covers models like the Heckel equation that can be applied to understand powder compaction and the Korsmeyer-Peppas model for characterizing drug release mechanisms.
This document provides an overview of fundamental concepts in controlled drug delivery systems. It discusses factors that influence the design of controlled release systems such as solubility, partition coefficient, molecular size, dose size, and drug stability. It also covers classifications of controlled release systems including dissolution controlled, diffusion controlled, and chemically controlled systems. The document concludes with a discussion of mathematical models used to evaluate the kinetics and mechanisms of drug release, including zero-order, first-order, Hixson-Crowell, Higuchi, and Korsmeyer-Peppas models.
This document provides an overview of toxicokinetic studies. It discusses the key principles and processes involved in toxicokinetics, including absorption, distribution, metabolism, and excretion of chemicals in the body. The four main toxicokinetic processes are absorption, which describes how chemicals enter systemic circulation; distribution throughout tissues; metabolism of parent compounds; and excretion of chemicals and metabolites from the body. Factors like dosage, membrane permeability, tissue permeability, protein binding, and biotransformation impact the movement and effects of chemicals in the body.
The document discusses biopharmaceutical and pharmacokinetic considerations in developing controlled release drug products. It defines controlled release as delivering a drug at a predetermined rate over a specified time period, while sustained release follows first-order kinetics and tries but does not always achieve zero-order kinetics. The document outlines factors like dose size, drug stability, solubility, and pharmacokinetics that must be considered for controlled release formulations. Developing controlled release products can provide benefits like improved patient compliance and comfort through reduced dosing frequency but also faces challenges like potential dose dumping and variable drug absorption.
COMPOUNDS THAT CANNOT BE FORMULATED AS CONTROLLED RELEASE SYSTEMArunpandiyan59
This document discusses compounds that are unsuitable for controlled release drug delivery systems. It provides terminology for different types of modified release products and discusses advantages and disadvantages of controlled release forms. Key factors that make drugs unsuitable for controlled release include short or long elimination half-lives, narrow therapeutic indices, poor absorption, extensive metabolism, variable bioavailability, and absorption issues related to solubility, stability, molecular size, and transport mechanisms. The document also discusses physiological factors such as distribution, metabolism, and protein binding that impact controlled release drug design.
Drug distribution and its clinical significanceDeepakPandey379
Drug distribution involves the movement of drugs from the bloodstream to tissues. This process determines the concentration of drugs in different parts of the body over time. Pharmacokinetic models like one-compartment and two-compartment models simulate drug absorption, distribution, and elimination. Factors like plasma protein binding, organ blood flow, and tissue permeability influence how drugs distribute between the blood and tissues. Therapeutic drug monitoring measures drug concentrations to ensure levels remain within a therapeutic range.
The document discusses sustained and controlled release drugs. It defines sustained release as maintaining therapeutic levels of a drug over a prolonged period after a single dose. Controlled release aims to deliver drugs at a predetermined rate according to bodily needs. Ideal controlled release delivers drugs at the body's dictated rate and solely to the site of action. This is achieved through modified dosage forms like controlled, timed, and sustained release forms. The document then discusses properties of drugs that make them suitable or unsuitable for controlled release formulations.
This document discusses factors that influence the absorption of drugs in the gastrointestinal tract. It outlines various physicochemical and dosage form factors that can impact a drug's solubility, dissolution rate, and absorption. The key physicochemical factors discussed are drug solubility, particle size, polymorphism, salt form, and lipophilicity. Theories of drug dissolution like the diffusion layer model and Danckwert's model are also summarized. The principle of bioequivalence studies and factors like disease state, gastrointestinal contents, and presystemic metabolism that can influence drug absorption are briefly covered as well.
This document provides an overview of clinical pharmacokinetics concepts. It defines key terms like pharmacokinetics, volume of distribution, clearance, and half-life. It describes pharmacokinetic processes like absorption, distribution, metabolism and excretion. It also discusses concentration versus time profiles for different drug administration routes and pharmacokinetic models like one compartment and two compartment models. The document aims to explain fundamental clinical pharmacokinetics principles and parameters.
This document discusses solubility and dissolution of solids in liquids, which are important processes in pharmaceutical solutions. It describes dissolution as a process where a substance goes into solution. Solubility is defined as the capacity of a solute to dissolve in a pure solvent. The document then discusses key steps in the dissolution process including removal of drug molecules from the solid state, formation of solvent cavities, and accommodation of drug molecules into the cavities. It presents the Noyes-Whitney equation, which describes dissolution rate in terms of surface area, concentration gradient, and diffusion coefficient. Finally, it notes that quality control dissolution testing is required by the FDA to ensure batch-to-batch uniformity of pharmaceutical formulations.
Effect of physico chemical properties on sustained and controll edAshutosh Gupta
This document discusses sustained and controlled release drug delivery systems. Sustained release provides an initial dose followed by gradual release over an extended period to maintain therapeutic levels. Controlled release aims to maintain constant drug levels over time. Key physicochemical properties that influence sustained and controlled release include aqueous solubility, partition coefficient, drug stability, protein binding, molecular size and diffusivity, and pka. These properties impact drug dissolution rate and other factors controlling absorption and delivery of drugs from these systems.
Sustained and Controlled Drug Delivery System.pptxHarshadaa bafna
This document provides information about sustained and controlled drug delivery systems. It begins with definitions of sustained release and controlled release, and discusses the advantages of maintaining consistent drug levels over time. It then covers topics like steady state concepts, diffusion mechanisms, dissolution models and polymer characterization as they relate to sustained and controlled release drug delivery. Evaluation methods for sustained release and controlled release tablets are also mentioned.
This document discusses pharmacokinetics and specifically the absorption process. It defines absorption as the movement of a drug from its site of administration into the bloodstream. The four main processes involved in pharmacokinetics - absorption, distribution, metabolism, and elimination (ADME) - are initially outlined. Several mechanisms of drug absorption in the gastrointestinal tract are then described in detail, including passive diffusion, carrier-mediated transport, phagocytosis, and others. Factors that can influence drug absorption and bioavailability are also summarized, such as pharmaceutical factors like drug solubility and formulation, as well as pharmacological factors like gastric emptying time.
This document provides information on factors affecting the design of controlled release drug delivery systems (CRDDS). It discusses selection of drug candidates, medical and biological rationales, physicochemical properties, in vitro and in vivo evaluation, and regulatory considerations. Dissolution-controlled and diffusion-controlled delivery systems are described. Key factors like solubility, partition coefficient, molecular size, dose size, and stability are explained. Different approaches for controlled release like matrix systems, encapsulation, reservoir devices are summarized.
Main Java[All of the Base Concepts}.docxadhitya5119
This is part 1 of my Java Learning Journey. This Contains Custom methods, classes, constructors, packages, multithreading , try- catch block, finally block and more.
A workshop hosted by the South African Journal of Science aimed at postgraduate students and early career researchers with little or no experience in writing and publishing journal articles.
Introduction to AI for Nonprofits with Tapp NetworkTechSoup
Dive into the world of AI! Experts Jon Hill and Tareq Monaur will guide you through AI's role in enhancing nonprofit websites and basic marketing strategies, making it easy to understand and apply.
A Strategic Approach: GenAI in EducationPeter Windle
Artificial Intelligence (AI) technologies such as Generative AI, Image Generators and Large Language Models have had a dramatic impact on teaching, learning and assessment over the past 18 months. The most immediate threat AI posed was to Academic Integrity with Higher Education Institutes (HEIs) focusing their efforts on combating the use of GenAI in assessment. Guidelines were developed for staff and students, policies put in place too. Innovative educators have forged paths in the use of Generative AI for teaching, learning and assessments leading to pockets of transformation springing up across HEIs, often with little or no top-down guidance, support or direction.
This Gasta posits a strategic approach to integrating AI into HEIs to prepare staff, students and the curriculum for an evolving world and workplace. We will highlight the advantages of working with these technologies beyond the realm of teaching, learning and assessment by considering prompt engineering skills, industry impact, curriculum changes, and the need for staff upskilling. In contrast, not engaging strategically with Generative AI poses risks, including falling behind peers, missed opportunities and failing to ensure our graduates remain employable. The rapid evolution of AI technologies necessitates a proactive and strategic approach if we are to remain relevant.
বাংলাদেশের অর্থনৈতিক সমীক্ষা ২০২৪ [Bangladesh Economic Review 2024 Bangla.pdf] কম্পিউটার , ট্যাব ও স্মার্ট ফোন ভার্সন সহ সম্পূর্ণ বাংলা ই-বুক বা pdf বই " সুচিপত্র ...বুকমার্ক মেনু 🔖 ও হাইপার লিংক মেনু 📝👆 যুক্ত ..
আমাদের সবার জন্য খুব খুব গুরুত্বপূর্ণ একটি বই ..বিসিএস, ব্যাংক, ইউনিভার্সিটি ভর্তি ও যে কোন প্রতিযোগিতা মূলক পরীক্ষার জন্য এর খুব ইম্পরট্যান্ট একটি বিষয় ...তাছাড়া বাংলাদেশের সাম্প্রতিক যে কোন ডাটা বা তথ্য এই বইতে পাবেন ...
তাই একজন নাগরিক হিসাবে এই তথ্য গুলো আপনার জানা প্রয়োজন ...।
বিসিএস ও ব্যাংক এর লিখিত পরীক্ষা ...+এছাড়া মাধ্যমিক ও উচ্চমাধ্যমিকের স্টুডেন্টদের জন্য অনেক কাজে আসবে ...
हिंदी वर्णमाला पीपीटी, hindi alphabet PPT presentation, hindi varnamala PPT, Hindi Varnamala pdf, हिंदी स्वर, हिंदी व्यंजन, sikhiye hindi varnmala, dr. mulla adam ali, hindi language and literature, hindi alphabet with drawing, hindi alphabet pdf, hindi varnamala for childrens, hindi language, hindi varnamala practice for kids, https://www.drmullaadamali.com
How to Build a Module in Odoo 17 Using the Scaffold MethodCeline George
Odoo provides an option for creating a module by using a single line command. By using this command the user can make a whole structure of a module. It is very easy for a beginner to make a module. There is no need to make each file manually. This slide will show how to create a module using the scaffold method.
Macroeconomics- Movie Location
This will be used as part of your Personal Professional Portfolio once graded.
Objective:
Prepare a presentation or a paper using research, basic comparative analysis, data organization and application of economic information. You will make an informed assessment of an economic climate outside of the United States to accomplish an entertainment industry objective.
1. PRESENTED BY :
ANANYA S
1ST M PHARM
PHARMACEUTICS
NGSMIPS
DIFFUSION, DISSOLUTION AND
PHARMACOKINETIC PARAMETERS
2. CONTENTS
• Introduction to diffusion
• Diffusion parameters
• Introduction to dissolution
• Dissolution parameters
• Introduction to pharmacokinetics
• Pharmacokinetic parameters
• Conclusion
• References
2
3. DIFFUSION
• Diffusion is the spontaneous migration of molecules from a region of high concentration to a
region of lower concentration and is result of the Brownian movement of the solute
molecule until the concentration is uniform throughout the system.
• The driving force for diffusion is usually the concentration gradient.
• Diffusion is observed during the release of the drug (from the dosage form), absorption
(across GIT or skin), distribution (into tissue),and even excretion (through kidney).
3
4. • Fick’s first and second law is useful for observing the magnitude of diffusion or
permeability. Higuchi equation is routinely used for evaluating the drug release
by diffusion mechanism.
Fick’s law:
• It states that the drug molecules diffuse from a region of higher concentration to
one of lower concentration until equilibrium is attained.
• Rate of diffusion is directly proportional to the concentration gradient across
the membrane.
4
5. • It is expressed as flux(J). equal to the rate of mass transfer across a unit surface area of a
barrier.
• 𝐽 = −𝐷
𝑑𝐶
𝑑𝑥
− −(2)
Where,
dC = change in concentration of material
D = diffusion coefficient of a penetrant
dx = change in distance
• D, may change in its value with high concentration.
• D is affected by temperature, pressure, solvent properties and chemical nature of diffusant.
5
6. Higuchi equation
• Equation indicates that the amount of drug released is a function of the square root to time.
𝑀 = 𝑘𝑡½
where k is a constant.
• A plot of amount of drug released versus square root of time will be linear, if the release of
drug from the matrix is diffusion controlled .
• This is known as Higuchi model or diffusion model
6
7. Diffusion parameters:
• The rate of drug transfer is directly proportional to the concentration gradient between GI
fluids and the blood compartment.
• Greater the area and lesser the thickness of the membrane, faster the diffusion; thus, more
rapid is the rate of drug absorption from the intestine than from the stomach.
• Greater the membrane/water partition coefficient of drug, faster the absorption; since the
membrane is lipiodal in nature, a lipophilic drug diffuses at a faster rate by solubilising in the
lipid layer of the membrane.
7
8. • The drug diffuses rapidly when the volume of GI fluid is low; conversely, dilution of
GI fluids decreases the drug concentration in these fluids (𝐶𝐺𝐼𝑇 ) and lower the
concentration gradient (𝐶𝐺𝐼𝑇 -C).
• The diffusion generally decreases with increase in the molecular weight of the
compound. Drugs having molecular weights between 100 – 400 Da are effectively
absorbed passively
8
9. DISSOLUTION
• Dissolution is a process by which solid solute dissolve in a solvent to yield a solution.
• A drug is released from solid dosage form and immediately go into molecular solution.
• Rate of dissolution is the amount of drug substance that goes in in solution per unit time
under standardized condition.
Dissolution process can be explained well by Noye’s – Whitney’s equation:
Where,
𝑑𝐶
𝑑𝑡
= 𝑘(𝐶𝑠 − 𝐶𝑏)
dC/dt= dissolution rate of the drug
k= dissolution rate constant
𝐶𝑠= concentration of the drug in the saturated layer
𝐶𝑏= concentration of the drug in the bulk of the solution at time t.
9
11. The Fick's first law of diffusion was included and modified the Noyes-Whitney's equation to:
𝑑𝑐
𝑑𝑡
=
𝐷𝐴𝐾𝑤/𝑜(𝐶𝑠 − 𝐶𝑏)
𝑉 × ℎ
−−−− −(1)
D = diffusion coefficient (diffusivity) of the drug
A = surface area of the dissolving solid
Kw/o = water/oil partition coefficient of the drug, considering the fact that dissolution body
fluids are aqueous.
V = volume of dissolution medium.
h = thickness of the stagnant layer.
(Cs-Cb) = concentration gradient for diffusion of drug.
11
12. PARAMETERS SYMBOL INFLUENCE ON DRUG DISSOLUTION
Diffusion coefficient of
drug
D Greater the value, faster the dissolution.
Diffusion decreases as the viscosity of
dissolution medium increases
Surface area of solid drug A Greater the surface area, faster the dissolution;
can be increased by micronization of drug.
Water/oil partition
coefficient of drug
Kw/o Higher the value, more the hydrophilicity and
faster the dissolution in aqueous fluids.
Concentration gradient (Cs-Cb) Greater the concentration gradient, faster the
diffusion and drug dissolution; can be
increased by increasing drug solubility and the
volume of dissolution medium
Thickness of stagnant
Layer
h More the thickness, lesser the diffusion and
drug dissolution
12
13. • Higher the value of KW/O the greater is the hydrophilicity and faster will be the
dissolution in aqueous fluids.
• The value of KW/O is nothing to do with the absorption of drug through biological
membrane.
13
14. Effect of agitation:
• The relationship between the intensity of agitation and the rate of dissolution varies
considerably according to the type of agitation used, degree of laminar and turbulent
flow in the system, the shape and design of the stirrer and the physicochemical properties
of the solid.
• Dissolution test using high speed agitation may lack discriminative value and can yield
misleading results.
• For basket method, 100rpm usually is utilised, while for the paddle procedure, 50-75rpm
is recommended.
14
15. Influence of pH of dissolution fluid:
• Changes in the pH exert the greatest effect in terms of drug solubility. Most of the drug are
weak electrolyte their degree of ionization mainly depends upon the pH of the biological
fluid.
• For weak acids, the dissolution rate increases with increasing pH whereas, for weak bases,
the dissolution rate increases with decreasing pH. Example: acetylsalicylic acid (pKa=3.5)
tablets and capsules, dissolution rate would be expected to increase if the pH of dissolution
medium was higher than 3.
• For tablets containing active ingredients, whose solubilities are independent of pH, the
dissolution rate does not vary significantly with changes in pH of the dissolution medium
unless they contain certain excipients that are influenced by pH
15
16. Effect of viscosity of the dissolution medium:
• dissolution rate is inversely proportional to the viscosity
• If the rate of contact at the interface is significantly quicker than the rate of transport, as it is
in diffusion controlled dissolution processes, it would be expected that the dissolution rate
decreases with an increase in viscosity.
• For instance, the rate of dissolution of zinc in HCl solution containing sucrose was inversely
proportional to the viscosity of the solution.
Effect of dissolution fluid:
• Selection of proper medium for dissolution testing depends largely on the physicochemical
properties of the drug.
• The nature of dissolution medium influences the solubility.
16
17. Volume of dissolution medium and sink conditions:
• The proper volume of dissolution medium depends on the solubility of drug selected fluid.
• If the drug poorly soluble in water a relatively large amount of fluid should be used if
complete dissolution is to be expected.
Effect of temperature of the dissolution medium:
• Drug solubility is temperature dependent, as the temperature increase the solubility of a drug
enhances therefore careful temperature control during the dissolution process is extremely
important.
• Generally, a temperature of 37˚C±0.5 is maintained during dissolution determination of oral
dosage forms and suppositories. For topical preparations, as low as 30˚C and 25 ˚C have
been used.
17
18. Effect of surface tension of the dissolution medium:
• If the drug is hydrophobic the dissolution rate is influenced primarily by the release processes,
whereas, for hydrophilic drugs the transfer process is more likely to be the rate limiting step.
• Incorporation of surface active agents in the dissolution medium, is expected to enhance the
dissolution rate of a poorly soluble drug in solid dosage forms by lowering the interfacial
tension between medium and solid surface and micelle formation.
• Addition of surfactant below the CMC (Critical Micelle Concentration) can increase
significantly the dissolution rate
18
19. Pharmacokinetic :
Pharmacokinetics is defined as the kinetics of drug absorption, distribution, metabolism and
excretion (KADME) and their relationship with the pharmacologic, therapeutic or
toxicologic response in man and animals.
Pharmacokinetic parameters are:
• Peak plasma concentration (Cmax)
• Time of peak concentration (tmax)
• Area under curve (AUC)
19
21. 1. Peak plasma concentration (Cmax)
• The point of maximum concentration of drug in plasma is called as the peak and the
concentration of drug at peak is known as peak plasma concentration. (peak height
concentration and maximum drug concentration.) Cmax is expressed in mg/mL(mcg)
• The peak plasma level depends upon;
Dose administered
Rate of absorption
Rate of elimination
• The peak represents point of time when absorption equals elimination rate drug
• Peak concentration is often related intensity pharmacologic response and should ideally be
above maximum effective concentration (MSC)but less than the maximum safe
concentration(MSC). 21
22. 2. Time of Peak Concentration (tmax)
• The time for drug to reach peak concentration in plasma called time of peak
concentration.
• It is expressed hours and useful in estimating the rate of absorption.
• Onset time and onset action are dependent upon tmax.
• Important in assessing the efficacy of drugs
3. Area Under Curve (AUC)
• It represents the total integrated area under the plasma level-time profile
• expresses total amount of drug comes into the systemic circulation after its administration.
• AUC is expressed mcg/mL*hours.
• It the most important parameter in evaluating bioavailability of drug from its dosage form
Represent extent of absorption 22
23. CONCLUSION :
The diffusion drug into tissues and their excretion through kidneys can be anticipated
through diffusion studies.
It has found its applications in determining the molecular weight of polymers, release of
drug from sustained/controlled release dosage forms.
Dissolution is very important step in the design of dosage form.
Various parameters such as thickness of membrane, volume of GI fluid, diffusion coefficient
(diffusivity) of the drug etc determines the rate of diffusion and dissolution rate.
Pharmacokinetic study is also important to identify variables that are important in
determining the potential of success of drug delivery system.
23
24. 1. Subrahmanyam C V S. Textbook of physical pharmaceutics. 3rd Ed.
Delhi. Vallabh Prakashan; 2015:96-112,133-148
2. Brahmankar D M , Sunil J B . Biopharmaceutics and
Pharmacokinetics. 3rd Ed. New Delhi. Vallabh Prakashan;2015:28-
31,237-240
3. Venkateswarlu V. Biopharmaceutics and Pharmacokinetics. 2nd Ed.
PharmaMed press;2012;45-69
REFERENCES :
24
Editor's Notes
the migration of solute molecules is a measure of escaping tendency of the solute in the environment to attain equilibrium
Change in the concentration of drug c in the membrane across unit distance x
Rate of change of con of dissolved material with time is directly proportionl to the con diff bet two sides of diffusion layer
Brunner Since the rapidity with which a drug dissolves depends on the Kw/o
Lipophilic =hydrophobic
This is the simplest and the most common theory for explaining dissolution.
Paddle app2(usp)
because of better penetration of the solvent into the tablet resulting in greater availability.
Direct relationship exists between the concentration of drug at site and con of drug in plasma
Treat acute condition like pain and insomnia
Represents extent of absorption……..chronic con lik asthma
Diffusion is a major process for absorption of more than 90% of the drugs. A drug is expected to be released from solid dosage forms and immediately go into molecular solution. Diffusion is observed during the release of drug and when the drug goes into solution the process of drug dissolution take place.